Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 3/2009

01.05.2009 | Overview

Prebiotics, probiotics, synbiotics in surgery—are they only trendy, truly effective or even dangerous?

verfasst von: Nada Rayes, Daniel Seehofer, Peter Neuhaus

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Despite advances in surgical technique and intensive care medicine, nosocomial bacterial infections frequently occur in patients after major abdominal surgery and have a negative impact on operative outcome and hospital costs. In parallel, the routine use of antibiotics led to the development of resistance. Some probiotics (living bacteria) and prebiotics (fibers) are able to stabilize the intestinal barrier and prevent bacterial translocation and infections. The aim of this article was to review all available experience with pro- and prebiotics in surgical trials.

Materials and methods

Medical databases were searched for animal trials and randomized controlled studies with pro- and prebiotics in surgical patients. Primary endpoint of all reported studies was the occurrence of bacterial infections. In addition, type and concentration of the pro- and prebiotics, duration of therapy, adverse events, and other effects were investigated.

Results

In three animal trials and in ten of the 15 clinical studies, probiotics or synbiotics led to a significant reduction of bacterial infection rates compared to the control groups. In two studies, there was a positive trend in the groups with synbiotics, but the results were not statistically significant. Two studies showed no effect, and in one study, the mortality rate was even higher in the synbiotic group. Except in the latter study, no severe adverse events were observed. The success of treatment depends on the synbiotic preparation and the length of therapy. Patients after surgery of the liver and pancreas and multiple trauma patients profited most from synbiotic treatment.

Conclusion

The existing randomized controlled trials demonstrated a positive effect of synbiotics in patients with high-risk operations; however, synbiotic preparations should be extensively tested before using them in clinical trials.
Literatur
1.
Zurück zum Zitat Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546–1554PubMedCrossRef Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546–1554PubMedCrossRef
2.
Zurück zum Zitat Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D (2006) Sepsis in European intensive care units: the SOAP study. Crit Care Med 34:344–353PubMedCrossRef Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D (2006) Sepsis in European intensive care units: the SOAP study. Crit Care Med 34:344–353PubMedCrossRef
3.
Zurück zum Zitat Barie PS, Williams MD, McCollam JS, Bates BM, Qualy RL, Lowry SF, Fry DE (2004) The PROWESS Surgical Evaluation Committee: benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis. Am J Surg 188:212–220PubMedCrossRef Barie PS, Williams MD, McCollam JS, Bates BM, Qualy RL, Lowry SF, Fry DE (2004) The PROWESS Surgical Evaluation Committee: benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis. Am J Surg 188:212–220PubMedCrossRef
4.
Zurück zum Zitat Wacha H, Hau T, Dittmer R, Ohmann C (1999) Risk factors associated with intraabdominal infections: a prospective multicenter study. Langenbeck`s Arch Surg 384:24–32CrossRef Wacha H, Hau T, Dittmer R, Ohmann C (1999) Risk factors associated with intraabdominal infections: a prospective multicenter study. Langenbeck`s Arch Surg 384:24–32CrossRef
5.
Zurück zum Zitat Sawyer RG, Raymond DP, Pelletier SJ et al (2001) Implications of 2,457 consecutive surgical infections entering year 2000. Ann Surg 233:867–874PubMedCrossRef Sawyer RG, Raymond DP, Pelletier SJ et al (2001) Implications of 2,457 consecutive surgical infections entering year 2000. Ann Surg 233:867–874PubMedCrossRef
6.
Zurück zum Zitat Farinas-Alvarez C, Farinas MC, Fernandez-Mazarrasa C et al (2000) Analysis of risk factors for nosocomial sepsis in surgical patients. Br J Surg 87:1076–1081PubMedCrossRef Farinas-Alvarez C, Farinas MC, Fernandez-Mazarrasa C et al (2000) Analysis of risk factors for nosocomial sepsis in surgical patients. Br J Surg 87:1076–1081PubMedCrossRef
7.
Zurück zum Zitat Wilson SE, Faulkner K (1998) Impact of anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections. Am Surg 64:402–407PubMed Wilson SE, Faulkner K (1998) Impact of anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections. Am Surg 64:402–407PubMed
8.
Zurück zum Zitat Rüden H, Daschner F, Schumacher M (1995) Nosokomiale Infektionen in Deutschland- Erfassung und Prävention (NIDEP Studie), Teil 1. Prävalenz nosokomialer Infektionen, Qualitätssicherung in der Krankenhaushygiene, Bd 56. Schriftenreihe des Bundesministeriums für Gesundheit. Nomos, Baden-Baden Rüden H, Daschner F, Schumacher M (1995) Nosokomiale Infektionen in Deutschland- Erfassung und Prävention (NIDEP Studie), Teil 1. Prävalenz nosokomialer Infektionen, Qualitätssicherung in der Krankenhaushygiene, Bd 56. Schriftenreihe des Bundesministeriums für Gesundheit. Nomos, Baden-Baden
9.
Zurück zum Zitat Brook I, Frazier EH (1999) Microbiology of subphrenic abscesses: a 14-year experience. Am Surg 65:1049–1053PubMed Brook I, Frazier EH (1999) Microbiology of subphrenic abscesses: a 14-year experience. Am Surg 65:1049–1053PubMed
10.
Zurück zum Zitat Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI (2005) Host–bacterial mutualism in the human intestine. Science 307:1915–1919PubMedCrossRef Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI (2005) Host–bacterial mutualism in the human intestine. Science 307:1915–1919PubMedCrossRef
11.
Zurück zum Zitat Hooper LV, Gordon JL (2001) Commensal host–bacterial relationships in the gut. Science 292:1115–1118PubMedCrossRef Hooper LV, Gordon JL (2001) Commensal host–bacterial relationships in the gut. Science 292:1115–1118PubMedCrossRef
12.
13.
Zurück zum Zitat MacFie J, Reddy BS, Gatt M, Jain PK, Sowdi R, Mitchell CJ (2006) Bacterial translocation studied in 927 patients over 13 years. Br J Surg 93(1):87–93PubMedCrossRef MacFie J, Reddy BS, Gatt M, Jain PK, Sowdi R, Mitchell CJ (2006) Bacterial translocation studied in 927 patients over 13 years. Br J Surg 93(1):87–93PubMedCrossRef
14.
Zurück zum Zitat Nieuwenhuijs VB, Verheem A, Duijvenbode-Beumer H, Visser MR, Verhoef J, Gooszen HG, Akkermans LM (1998) The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats. Ann Surg 228:188–93PubMedCrossRef Nieuwenhuijs VB, Verheem A, Duijvenbode-Beumer H, Visser MR, Verhoef J, Gooszen HG, Akkermans LM (1998) The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats. Ann Surg 228:188–93PubMedCrossRef
15.
Zurück zum Zitat Deitch EA, Dazhong X, Naruhn MB, Deitch DC, Qi L, Marino AA (1995) Elemental diet and iv-TPN-induced bacterial translocation is associated with loss of intestinal mucosal barrier function against bacteria. Ann Surg 221:299–307PubMedCrossRef Deitch EA, Dazhong X, Naruhn MB, Deitch DC, Qi L, Marino AA (1995) Elemental diet and iv-TPN-induced bacterial translocation is associated with loss of intestinal mucosal barrier function against bacteria. Ann Surg 221:299–307PubMedCrossRef
16.
Zurück zum Zitat Bengmark S (1999) Gut environment and immune function. Curr Opin Clin Nutr Metab Care 2:83–85PubMedCrossRef Bengmark S (1999) Gut environment and immune function. Curr Opin Clin Nutr Metab Care 2:83–85PubMedCrossRef
17.
Zurück zum Zitat Seehofer D, Rayes N, Schiller R et al (2004) Probiotics partly reverse increased bacterial translocation after simultaneous liver resection and colonic anastomosis in rats. J Surg Res 117:262–271PubMedCrossRef Seehofer D, Rayes N, Schiller R et al (2004) Probiotics partly reverse increased bacterial translocation after simultaneous liver resection and colonic anastomosis in rats. J Surg Res 117:262–271PubMedCrossRef
18.
Zurück zum Zitat Naaber P, Smidt I, Tamme K, Liigant A, Tapfer H, Mikelsaar M, Talvik R (2000) Translocation of indigenous microflora in an experimental model of sepsis. J Med Microbiol 49:431–439PubMed Naaber P, Smidt I, Tamme K, Liigant A, Tapfer H, Mikelsaar M, Talvik R (2000) Translocation of indigenous microflora in an experimental model of sepsis. J Med Microbiol 49:431–439PubMed
19.
Zurück zum Zitat Runkel NSF, Moody FG, Smith GS, Rodriguez LF, LaRocco MT, Miller TA (1991) The role of the gut in the development of sepsis in acute pancreatitis. J Surg Res 51:18–23PubMedCrossRef Runkel NSF, Moody FG, Smith GS, Rodriguez LF, LaRocco MT, Miller TA (1991) The role of the gut in the development of sepsis in acute pancreatitis. J Surg Res 51:18–23PubMedCrossRef
20.
Zurück zum Zitat Tran DD, Cuesta MA, van Leeuwen PA, Nauta JJ, Wesdorp RI (1993) Risk factors for multiple organ system failure and death in critically injured patients. Surgery 114:21–30PubMed Tran DD, Cuesta MA, van Leeuwen PA, Nauta JJ, Wesdorp RI (1993) Risk factors for multiple organ system failure and death in critically injured patients. Surgery 114:21–30PubMed
21.
Zurück zum Zitat Lane WA (1908) Results of the operative treatment of chronic constipation. Br Med J 1:126CrossRef Lane WA (1908) Results of the operative treatment of chronic constipation. Br Med J 1:126CrossRef
22.
Zurück zum Zitat Mulder JG, Wiersma WE, Welling GW, van der Waaij D (1984) Low dose oral tobramycin treatment for selective decontamination of the digestive tract: a study in human volunteers. J Antimicrob Chemother 13(5):495–504 MayPubMedCrossRef Mulder JG, Wiersma WE, Welling GW, van der Waaij D (1984) Low dose oral tobramycin treatment for selective decontamination of the digestive tract: a study in human volunteers. J Antimicrob Chemother 13(5):495–504 MayPubMedCrossRef
23.
Zurück zum Zitat Hellinger WC, Yao JD, Alvarez S et al (2002) A randomized, prospective, double-blind evaluation of selective bowel decontamination. Tranplantation 73(12):1904–1909CrossRef Hellinger WC, Yao JD, Alvarez S et al (2002) A randomized, prospective, double-blind evaluation of selective bowel decontamination. Tranplantation 73(12):1904–1909CrossRef
24.
Zurück zum Zitat Zwaveling JH, Maring JK, Klompmaker IJ et al (2002) Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo-controlled trial in liver transplant recipients. Crit Care Med 30(6):1204–1209PubMedCrossRef Zwaveling JH, Maring JK, Klompmaker IJ et al (2002) Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo-controlled trial in liver transplant recipients. Crit Care Med 30(6):1204–1209PubMedCrossRef
25.
Zurück zum Zitat O’May GA, Reynolds N, Smith AR, Kennedy A, Macfarlane GT (2005) Effect of pH and antibiotics on microbial overgrowth in the stomachs and duodena of patients undergoing percutaneous endoscopic gastrostomy feeding. J Clin Microbiol 43(7):3059–3065PubMedCrossRef O’May GA, Reynolds N, Smith AR, Kennedy A, Macfarlane GT (2005) Effect of pH and antibiotics on microbial overgrowth in the stomachs and duodena of patients undergoing percutaneous endoscopic gastrostomy feeding. J Clin Microbiol 43(7):3059–3065PubMedCrossRef
26.
Zurück zum Zitat Meyer E, Schwab F, Gastmeier P, Rueden H, Daschner FD (2006) Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004. Infection 34(6):303–309 DecPubMedCrossRef Meyer E, Schwab F, Gastmeier P, Rueden H, Daschner FD (2006) Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004. Infection 34(6):303–309 DecPubMedCrossRef
27.
Zurück zum Zitat Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC (2008) Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin Infect Dis 46(5):668–674PubMedCrossRef Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC (2008) Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin Infect Dis 46(5):668–674PubMedCrossRef
28.
Zurück zum Zitat Shlaes DM, Projan SJ, Edwards JE (2004) Antibiotic discovery: state of the state. ASM News 70:275–281 Shlaes DM, Projan SJ, Edwards JE (2004) Antibiotic discovery: state of the state. ASM News 70:275–281
29.
Zurück zum Zitat Schrezemeier J, de Vrese M (2001) Probiotics, prebiotics and synbiotics-approaching a definition. Am J Clin Nutr 73:361–364 Schrezemeier J, de Vrese M (2001) Probiotics, prebiotics and synbiotics-approaching a definition. Am J Clin Nutr 73:361–364
30.
Zurück zum Zitat Mechnikov I (1908) The prolongation of human life, 1st ed. G.P. Putnams Sons, New York. Mechnikov I (1908) The prolongation of human life, 1st ed. G.P. Putnams Sons, New York.
31.
Zurück zum Zitat Lin HC, Su BH, Chen AC et al (2005) Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Outcome and cost of intensive care for very low birth weight infants. Pediatrics 115(1):1–4PubMed Lin HC, Su BH, Chen AC et al (2005) Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Outcome and cost of intensive care for very low birth weight infants. Pediatrics 115(1):1–4PubMed
32.
Zurück zum Zitat D’Souza AL, Raj Cumar C, Cooke J et al (2002) Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 324(7350):1361PubMedCrossRef D’Souza AL, Raj Cumar C, Cooke J et al (2002) Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 324(7350):1361PubMedCrossRef
33.
Zurück zum Zitat McCarthy J, O’Mahony L, Dunne C et al (2001) An open trial of a novel probiotic as an alternative to steroids in mild/moderately active Crohn’s disease. Gut 49(Suppl 3):A2447 McCarthy J, O’Mahony L, Dunne C et al (2001) An open trial of a novel probiotic as an alternative to steroids in mild/moderately active Crohn’s disease. Gut 49(Suppl 3):A2447
34.
Zurück zum Zitat Liu Q, Duan ZP, Ha da K, Bengmark S, Kurtovic J, Riordan SM (2004) Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 39(5):1441–1449PubMedCrossRef Liu Q, Duan ZP, Ha da K, Bengmark S, Kurtovic J, Riordan SM (2004) Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 39(5):1441–1449PubMedCrossRef
35.
Zurück zum Zitat Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, DeSimone C, Song XY, Diehl AM (2003) Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37:343–350PubMedCrossRef Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, DeSimone C, Song XY, Diehl AM (2003) Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37:343–350PubMedCrossRef
36.
Zurück zum Zitat Kalliomäki M, Salminen S, Arvilommi H et al (2001) Probiotics in primary prevention of atopic disease: a randomised, placebo-controlled trial. Lancet 357:1076–1079PubMedCrossRef Kalliomäki M, Salminen S, Arvilommi H et al (2001) Probiotics in primary prevention of atopic disease: a randomised, placebo-controlled trial. Lancet 357:1076–1079PubMedCrossRef
37.
Zurück zum Zitat Reid G, Charbonneau D, Erb J et al (2003) Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 35(2):131–134PubMedCrossRef Reid G, Charbonneau D, Erb J et al (2003) Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 35(2):131–134PubMedCrossRef
38.
Zurück zum Zitat Servin AL (2004) Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbial Rev 28:405–440CrossRef Servin AL (2004) Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbial Rev 28:405–440CrossRef
39.
Zurück zum Zitat Marco ML, Pavan S, Kleerezebem M (2006) Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol 17:204–210PubMed Marco ML, Pavan S, Kleerezebem M (2006) Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol 17:204–210PubMed
40.
Zurück zum Zitat Mack DR, Michail S, Wel S et al (1999) Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 276:G941–950PubMed Mack DR, Michail S, Wel S et al (1999) Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 276:G941–950PubMed
41.
Zurück zum Zitat Schlee M, Harder J, Köten B, Stange EF, Wehkamp J, Fellermann A (2008) Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin Exp Immunol 151(3):528–535PubMedCrossRef Schlee M, Harder J, Köten B, Stange EF, Wehkamp J, Fellermann A (2008) Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin Exp Immunol 151(3):528–535PubMedCrossRef
42.
Zurück zum Zitat Bengmark S (2005) Bioecological control of the gastrointestinal tract: the role of flora and supplemented probiotics and synbiotics. Gastroenterol Clin North Am 34:413–436PubMedCrossRef Bengmark S (2005) Bioecological control of the gastrointestinal tract: the role of flora and supplemented probiotics and synbiotics. Gastroenterol Clin North Am 34:413–436PubMedCrossRef
43.
Zurück zum Zitat Otte JM, Podolsky DK (2004) Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol 286:613–626CrossRef Otte JM, Podolsky DK (2004) Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol 286:613–626CrossRef
44.
Zurück zum Zitat Hart AL, Lammers K, Brigidi P, Vitali B, Rizzello F, Gionchetti P, Campieri M, Kamm MA Knight SC, Stagg AJ (2004) Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53:1602–1609PubMedCrossRef Hart AL, Lammers K, Brigidi P, Vitali B, Rizzello F, Gionchetti P, Campieri M, Kamm MA Knight SC, Stagg AJ (2004) Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53:1602–1609PubMedCrossRef
45.
Zurück zum Zitat Sheih YH, Chiang BL, Wang LH, Liao CK, Gill HS (2001) Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr 20:149–156PubMed Sheih YH, Chiang BL, Wang LH, Liao CK, Gill HS (2001) Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr 20:149–156PubMed
46.
Zurück zum Zitat Niers LE, Timmermann HM, Rijkers GT, van Bleek GM, van Uden NO, Knol EF (2005) Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy 35:1481–1489PubMedCrossRef Niers LE, Timmermann HM, Rijkers GT, van Bleek GM, van Uden NO, Knol EF (2005) Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy 35:1481–1489PubMedCrossRef
47.
Zurück zum Zitat Perdigon G, Nader de Macias ME, Alvarez S et al (1988) Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus. Immunology 63:17–23PubMed Perdigon G, Nader de Macias ME, Alvarez S et al (1988) Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus. Immunology 63:17–23PubMed
48.
Zurück zum Zitat Kaila M, Isolauri E, Soppi E et al (1992) Enhancement of the circulating antibody secreting cell response in human diarrhoea by a human Lactobacillus strain. Pediatr Res 32:141–144PubMed Kaila M, Isolauri E, Soppi E et al (1992) Enhancement of the circulating antibody secreting cell response in human diarrhoea by a human Lactobacillus strain. Pediatr Res 32:141–144PubMed
49.
Zurück zum Zitat Salminen S, Bouley C, Boutron-Ruault MC et al (1998) Functional food science and gastrointestinal physiology and function. Br J Nutr 80(Suppl. 1):147–171CrossRef Salminen S, Bouley C, Boutron-Ruault MC et al (1998) Functional food science and gastrointestinal physiology and function. Br J Nutr 80(Suppl. 1):147–171CrossRef
50.
Zurück zum Zitat Wang X, Andersson R, Soltesz V, Guo W, Bengmark S (1993) Water-soluble ethylhydroxy Cellulose prevents bacterial translocation induced by major liver resection in the rat. Ann Surg 217:155–167PubMedCrossRef Wang X, Andersson R, Soltesz V, Guo W, Bengmark S (1993) Water-soluble ethylhydroxy Cellulose prevents bacterial translocation induced by major liver resection in the rat. Ann Surg 217:155–167PubMedCrossRef
51.
Zurück zum Zitat Tsunoda A, Shibusawa M, Tsunoda Y, Watanabe M, Nomoto K, Kusano M (2002) Effect of Lactobacillus casei on a novel murine model of abdominal sepsis. J Surg Res 107(1):37–43PubMed Tsunoda A, Shibusawa M, Tsunoda Y, Watanabe M, Nomoto K, Kusano M (2002) Effect of Lactobacillus casei on a novel murine model of abdominal sepsis. J Surg Res 107(1):37–43PubMed
52.
Zurück zum Zitat Seehofer D, Rayes N, Schiller RA, Stockmann M, Müller AR, Schirmeier A, Schaeper F, Tullius SG, Bengmark S, Neuhaus P (2004) Probiotics partly reverse increased bacterial translocation after simultaneous liver resection and colonic anastomosis in the rat. J Surg Res 117:262–271PubMedCrossRef Seehofer D, Rayes N, Schiller RA, Stockmann M, Müller AR, Schirmeier A, Schaeper F, Tullius SG, Bengmark S, Neuhaus P (2004) Probiotics partly reverse increased bacterial translocation after simultaneous liver resection and colonic anastomosis in the rat. J Surg Res 117:262–271PubMedCrossRef
53.
Zurück zum Zitat McNaught CE, Woodcock NP, MacFie J, Mitchell CJ (2002) A prospective randomised study of the probiotic Lactobacillus plantarum 299v on indices of gut barrier function in elective surgical patients. Gut 51:827–831PubMedCrossRef McNaught CE, Woodcock NP, MacFie J, Mitchell CJ (2002) A prospective randomised study of the probiotic Lactobacillus plantarum 299v on indices of gut barrier function in elective surgical patients. Gut 51:827–831PubMedCrossRef
54.
Zurück zum Zitat Anderson ADG, McNaught CE, Jain PK, MacFie J (2004) Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 53:241–245PubMedCrossRef Anderson ADG, McNaught CE, Jain PK, MacFie J (2004) Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 53:241–245PubMedCrossRef
55.
Zurück zum Zitat Reddy BS, MacFie J, Gatt M, Larsen CN, Jensen SS, Leser TD (2007) Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. Br J Surg 94:546–554PubMedCrossRef Reddy BS, MacFie J, Gatt M, Larsen CN, Jensen SS, Leser TD (2007) Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. Br J Surg 94:546–554PubMedCrossRef
56.
Zurück zum Zitat Rayes N, Hansen S, Seehofer D et al (2002) Early enteral supply of fiber and lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition 18:609–615PubMedCrossRef Rayes N, Hansen S, Seehofer D et al (2002) Early enteral supply of fiber and lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition 18:609–615PubMedCrossRef
57.
Zurück zum Zitat Pisters PWT, Hudec WA, Hess KR, Lee JE, Vauthey JN, Lahoti S, Raijman I, Evans DB (2001) Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive cases. Ann Surg 234(1):47–55PubMedCrossRef Pisters PWT, Hudec WA, Hess KR, Lee JE, Vauthey JN, Lahoti S, Raijman I, Evans DB (2001) Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive cases. Ann Surg 234(1):47–55PubMedCrossRef
58.
Zurück zum Zitat Jagannath P, Dhir V, Shrikande S, Shah RC, Mullerpatan P, Mohandas KM (2005) Effect of preoperative biliary stenting on immediate outcome after pancreatoduodenectomy. Br J Surg 92:356–361PubMedCrossRef Jagannath P, Dhir V, Shrikande S, Shah RC, Mullerpatan P, Mohandas KM (2005) Effect of preoperative biliary stenting on immediate outcome after pancreatoduodenectomy. Br J Surg 92:356–361PubMedCrossRef
59.
Zurück zum Zitat Nomura T, Tsuchiya Y, Nashimoto A et al (2007) Probiotics reduce infectious complications after pancreaticoduodenectomy. Hepato-Gastroenterology 54:661–663PubMed Nomura T, Tsuchiya Y, Nashimoto A et al (2007) Probiotics reduce infectious complications after pancreaticoduodenectomy. Hepato-Gastroenterology 54:661–663PubMed
60.
Zurück zum Zitat Rayes N, Seehofer D, Theruvath T et al (2007) Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy. Ann Surg 246:36–41PubMedCrossRef Rayes N, Seehofer D, Theruvath T et al (2007) Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy. Ann Surg 246:36–41PubMedCrossRef
61.
Zurück zum Zitat Olah A, Belagyi T, Issekutz A, Gamal ME, Bengmark S (2002) Randomized clinical trial of specific Lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 89:1103–1107PubMedCrossRef Olah A, Belagyi T, Issekutz A, Gamal ME, Bengmark S (2002) Randomized clinical trial of specific Lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 89:1103–1107PubMedCrossRef
62.
Zurück zum Zitat Olah A, Belagyi T, Poto L, Romics L Bengmark S (2007) Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double-blind study. Hepato-Gastroenterology 54:590–594PubMed Olah A, Belagyi T, Poto L, Romics L Bengmark S (2007) Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double-blind study. Hepato-Gastroenterology 54:590–594PubMed
63.
Zurück zum Zitat Besselink MGH, van Santvoort HC, Buskens E et al (2008) Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371:651–659PubMedCrossRef Besselink MGH, van Santvoort HC, Buskens E et al (2008) Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371:651–659PubMedCrossRef
64.
Zurück zum Zitat Shigata H, Nagino M, Kamiya J et al (2002) Bacteremia after hepatectomy: an analysis of a single-center, 10-year experience with 407 patients. Langenbeck’s Arch Surg 387:117–124CrossRef Shigata H, Nagino M, Kamiya J et al (2002) Bacteremia after hepatectomy: an analysis of a single-center, 10-year experience with 407 patients. Langenbeck’s Arch Surg 387:117–124CrossRef
65.
Zurück zum Zitat Togo S, Matsuo K, Tanaka K, Matsumoto C, Shimizu T, Ueda M, Morioka D, Nagano Y, Endo I, Shimada H (2007) Perioperative infection control and its effectiveness in hepatectomy patients. J Gastroenterol Hepatol 22(11):1942–1948 NovPubMedCrossRef Togo S, Matsuo K, Tanaka K, Matsumoto C, Shimizu T, Ueda M, Morioka D, Nagano Y, Endo I, Shimada H (2007) Perioperative infection control and its effectiveness in hepatectomy patients. J Gastroenterol Hepatol 22(11):1942–1948 NovPubMedCrossRef
66.
Zurück zum Zitat Wang X, Andersson R, Soltesz V, Wang L, Bengmark S (1993) Effect of portal hypertension on bacterial translocation induced by major liver resection in rats. Eur J Surg 159:343–350PubMed Wang X, Andersson R, Soltesz V, Wang L, Bengmark S (1993) Effect of portal hypertension on bacterial translocation induced by major liver resection in rats. Eur J Surg 159:343–350PubMed
67.
Zurück zum Zitat Wang X, Guo WD, Wang Q, Andersson R, Ekblad E, Soltesz V, Bengmark S (1994) The association between enteric bacterial overgrowth and gastrointestinal motility after subtotal resection or portal vein obstruction in rats. Eur J Surg 160:153–160PubMed Wang X, Guo WD, Wang Q, Andersson R, Ekblad E, Soltesz V, Bengmark S (1994) The association between enteric bacterial overgrowth and gastrointestinal motility after subtotal resection or portal vein obstruction in rats. Eur J Surg 160:153–160PubMed
69.
Zurück zum Zitat Kanazawa H, Nagino M, Kamiya S et al (2005) Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 390:104–113PubMedCrossRef Kanazawa H, Nagino M, Kamiya S et al (2005) Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 390:104–113PubMedCrossRef
70.
Zurück zum Zitat Sugawara G, Nagino M, Nishio H et al (2006) Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery. A randomized controlled trial. Ann Surg 244:706–714PubMedCrossRef Sugawara G, Nagino M, Nishio H et al (2006) Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery. A randomized controlled trial. Ann Surg 244:706–714PubMedCrossRef
71.
Zurück zum Zitat Rolando N, Philpott-Howard J, Williams R et al (1996) Bacterial and fungal infection in acute liver failure. Semin Liver Dis 16:389–402PubMedCrossRef Rolando N, Philpott-Howard J, Williams R et al (1996) Bacterial and fungal infection in acute liver failure. Semin Liver Dis 16:389–402PubMedCrossRef
72.
Zurück zum Zitat Rayes N, Bechstein WO, Keck H, Blumhardt G, Lohmann R, Neuhaus P (1995) Todesursachen nach Lebertransplantation: eine Analyse von 41 Fällen bei 382 Patienten. Zentralbl Chir 120:435–438PubMed Rayes N, Bechstein WO, Keck H, Blumhardt G, Lohmann R, Neuhaus P (1995) Todesursachen nach Lebertransplantation: eine Analyse von 41 Fällen bei 382 Patienten. Zentralbl Chir 120:435–438PubMed
73.
Zurück zum Zitat Hollenbaek CS, Alfrey EJ, Souba WW (2001) The effect of surgical site infection on outcomes and resource utilization after liver transplantation. Surgery 130:388–395CrossRef Hollenbaek CS, Alfrey EJ, Souba WW (2001) The effect of surgical site infection on outcomes and resource utilization after liver transplantation. Surgery 130:388–395CrossRef
74.
Zurück zum Zitat Rayes N, Seehofer D, Hansen S, Boucsein K, Müller AR, Serke S, Bengmark S, Neuhaus P (2002) Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 74(1):123–128PubMedCrossRef Rayes N, Seehofer D, Hansen S, Boucsein K, Müller AR, Serke S, Bengmark S, Neuhaus P (2002) Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 74(1):123–128PubMedCrossRef
75.
Zurück zum Zitat Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, Bengmark S, Neuhaus P (2005) Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation—a randomized, double-blind trial. Am J Transplant 5:125–130PubMedCrossRef Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, Bengmark S, Neuhaus P (2005) Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation—a randomized, double-blind trial. Am J Transplant 5:125–130PubMedCrossRef
76.
Zurück zum Zitat Hammond JM, Potgieter PD, Saunders GL (1994) Selective decontamination of the digestive tract in multiple trauma patients—is there a role? Results of a prospective, double-blind, randomized trial. Crit Care Med 22(1):33–39 JanPubMed Hammond JM, Potgieter PD, Saunders GL (1994) Selective decontamination of the digestive tract in multiple trauma patients—is there a role? Results of a prospective, double-blind, randomized trial. Crit Care Med 22(1):33–39 JanPubMed
77.
Zurück zum Zitat Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, Kazamias P, Eleftheriadis E (2006) Benefits of a synbiotic formula (Synbiotic 2000forte) in critically ill trauma patients: early results of a randomized controlled trial. World J Surg 30:1848–1855PubMedCrossRef Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, Kazamias P, Eleftheriadis E (2006) Benefits of a synbiotic formula (Synbiotic 2000forte) in critically ill trauma patients: early results of a randomized controlled trial. World J Surg 30:1848–1855PubMedCrossRef
78.
Zurück zum Zitat Spindler-Vesel A, Bengmark S, Vovk I, Cerovic O, Kompan L (2007) Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. J Parent Enteral Nutr 31:119–126CrossRef Spindler-Vesel A, Bengmark S, Vovk I, Cerovic O, Kompan L (2007) Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. J Parent Enteral Nutr 31:119–126CrossRef
79.
Zurück zum Zitat Isolauri E, Salminen S (2005) Probiotics, gut inflammation and barrier function. Gastroenterol Clin N Am 34:437–450CrossRef Isolauri E, Salminen S (2005) Probiotics, gut inflammation and barrier function. Gastroenterol Clin N Am 34:437–450CrossRef
Metadaten
Titel
Prebiotics, probiotics, synbiotics in surgery—are they only trendy, truly effective or even dangerous?
verfasst von
Nada Rayes
Daniel Seehofer
Peter Neuhaus
Publikationsdatum
01.05.2009
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 3/2009
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-008-0445-9

Weitere Artikel der Ausgabe 3/2009

Langenbeck's Archives of Surgery 3/2009 Zur Ausgabe

Case Management and Clinical Consequences

Sudden death after open gastric bypass surgery

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Traumatologische Notfälle Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.